Investor Talk : AbbVie Ventures
Thu, Dec 03
|PSCC, The Hive
The PSCC Investor Talk series brings together startups and innovative companies from the PSCC Connect community with a leading investment fund active in life sciences and oncology. Upon invitation only, for PSCC Connect Start-ups


Time & Location
Dec 03, 2026, 12:00 PM – 2:00 PM
PSCC, The Hive, 125 Rue Edouard Vaillant, 94800 Villejuif, France
About the event
The PSCC Investor Talk series brings together startups and innovative companies from the PSCC Connect community with a leading investment fund active in life sciences and oncology.
Each edition offers a direct and informal exchange between entrepreneurs and investors: the invited fund presents its investment strategy, current priorities, and portfolio focus. The talk is followed by an open discussion and networking reception.
For this edition, we will welcome Joachim Vogt, Director, Search & Evaluation International at AbbVie.
During this informal session, Joachim Vogt will give us a behind-the-scenes view of how a corporate VC assesses scientific innovation, management teams, and market potential in today's highly competitive funding environment.
The discussion will cover :
how AbbVie finds and supports breakthrough science in Europe at the discovery and preclinical stages, mainly Seed or Series A,
what AbbVie looks for in early-stage projects,
what partners gain beyond funding, including access to AbbVie’s internal experts across drug development.
This session will leave plenty of time for discussion and networking over lunch.